ALDH7A1 and hepatocellular carcinoma: Mechanistic studies: We conducted the most molecular and mechanistic studies related to how PDE inhibitors modulate molecular mechanisms leading to signaling pathways in HCC and identified potential biomarkers to predict the response of patients who would benefit from receiving PDE inhibitor-based therapies.